Perioperative methadone prescribing and association with respiratory depression

Sarah E. Bova, PharmD; Rachel M. Kruer, PharmD; Suzanne A. Nesbit, PharmD; Michael C. Grant, MD; Andrew S. Jarrell, PharmD

doi:10.5055/jom.2020.0602

Authors

Sarah E. Bova, PharmD https://orcid.org/0000-0002-6121-5545
Rachel M. Kruer, PharmD
Suzanne A. Nesbit, PharmD
Michael C. Grant, MD
Andrew S. Jarrell, PharmD

DOI:

https://doi.org/10.5055/jom.2020.0602

Keywords:

methadone, opioids, respiratory depression

Abstract

Objective: Over 80 percent of surgery patients experience acute post-operative pain and less than half feel their pain is adequately controlled. Patients receiving chronic opioids, including methadone, are at the highest risk of inadequate pain control. Guidelines do not provide specific recommendations for analgesia management in this population. The purpose of this study was to evaluate the association between post-operative methadone use and respiratory depression.

Design: This study was a single center, retrospective, cohort study of adult patients.

Setting: Patients included were admitted to a single academic medical center from July 2016 to September 2018.

Participants: Medical records of adult inpatients with an operative procedure who received perioperative methadone were reviewed.

Main outcome measures: Preoperative methadone use was evaluated for all patients. Post-operative methadone dosing was compared to preoperative methadone dosing. Post-operative respiratory depression was evaluated. Logistic regression was performed to identify risk factors for respiratory depression.

Results: Two hundred ninety-eight patients were included in the study. Patients were divided into groups based on preoperative methadone use. Over 90 percent of patients were on preoperative methadone. There were no significant differences in baseline characteristics between groups. In the initial seven post-operative days, 14.8 percent of patients had documented respiratory depression. Respiratory depression was more common among patients who were newly initiated on methadone post-operatively. Factors associated with respiratory depression included male sex, increased age, and new post-operative methadone initiation.

Conclusions: Most patients who were administered post-operative methadone were on preoperative methadone. New post-operative methadone initiation was a risk factor for respiratory depression.

Author Biographies

Sarah E. Bova, PharmD

Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, Maryland

Rachel M. Kruer, PharmD

Department of Pharmacy, Indiana University Health, Indianapolis, Indiana

Suzanne A. Nesbit, PharmD

Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, Maryland

Michael C. Grant, MD

Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins Hospital, Baltimore, Maryland

Andrew S. Jarrell, PharmD

Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, Maryland

References

Chou R, Gordon DB, Leon-Casasola OA, et al.: Management of postoperative pain: A clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists’ Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain. 2016; 17(2): 131-157.

Alford DP, Compton P, Samet JH.: Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med. 2006; 144(2): 127-134.

American Society of Anesthesiologists Task Force on Acute Pain Management. Practice guidelines for acute pain management in the perioperative setting: An updated report by the American Society of Anesthesiologists Task Force on acute pain management. Anesthesiology. 2012; 116(2): 248-273.

Chou R, Cruciana RA, Fiellin DA, et al.: Methadone safety: A clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society. J Pain. 2014; 15(4): 321-337.

Food and Drug Administration.: Public Health Advisory: Methadone Use for Pain Control May Result in Death and Life-Threatening Changes in Breathing and Heart Beat. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration, 2006.

Coluzzi F, Bifulco F, Cuomo A, et al.: The challenge of perioperative pain management in opioid-tolerant patients. Ther Clin Risk Manage. 2017; 13: 1163-1173.

Huxtable CA, Roberts LJ, Somogyi AA, et al.: Acute pain management in opioid-tolerant patients: A growing challenge. Anaesth Intensive Care Med. 2011; 39(5): 804-823.

Peng PW, Tumber PS, Gourlay D.: Review article: Perioperative pain management of patients on methadone therapy. Can J Anesth. 2005; 52(5): 513-523.

Zador D, Sunjic S.: Deaths in methadone maintenance treatment in New South Wales, Australia 1990-1995. Addiction. 2000; 95(1): 77-84.

Wick EC, Grant MC, Wu CL.: Postoperative multimodal analgesia pain management with nonopioid analgesics and techniques: A review. JAMA Surg. 2017; 152(7): 691-697.

Ernst E, Bartu A, Popescu A, et al.: Methadone-related deaths in Western Australia 1993–99. Aust N Z J Public Health. 2007; 26(4): 364-370.

Marquez-Lara A, Hutchinson ID, Nuñez F, et al.: Nonsteroidal anti-inflammatory drugs and bone-healing: A systematic review of research quality. JBJS Rev. 2016; 4(3): e4.

Palmer JD, Sparrow OC, Iannotti F.: Postoperative hematoma: A 5-year survey and identification of avoidable risk factors. Neurosurgery. 1994; 35(6): 1061-1064.

Elia N, Lysakowski C, Tramèr MR.: Does multimodal analgesia with acetaminophen, nonsteroidal anti-inflammatory drugs, or selective cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine offer advantages over morphine alone? Meta-analyses of randomized trials. Anesthesiology. 2005; 103(6): 1296-1304.

Gobble RM, Hoang HL, Kachniarz B, et al.: Ketorolac does not increase perioperative bleeding: a meta-analysis of randomized controlled trials. Plast Reconstr Surg. 2014; 133(3): 741-755.

Dunn LK, Yerra S, Fang S, et al.: Safety profile of intraoperative methadone for analgesia after major spine surgery: An observational study of 1,478 patients. J Opioid Manag. 2018; 14(2): 83-87.

Gourlay GK, Wilson PR, Glynn CJ.: Pharmacodynamics and pharmacokinetics of methadone during the perioperative period. Anesthesiology. 1982; 57(6): 458-467.

Nadpara PA, Joyce AR, Murrelle EL, et al.: Risk factors for serious prescription opioid-induced respiratory depression or overdose: Comparison of commercially insured and veterans health affairs populations. Pain Med. 2018; 19(1): 79-96.

Kessler ER, Shah M, Gruschkus SK, et al.: Cost and quality implications of opioid-based postsurgical pain control using administrative claims data from a large health system: Opioid-related adverse events and their impact on clinical and economic outcomes. Pharmacotherapy. 2013; 33(4): 383-391.

Gupta K, Nagappa M, Prasad A.: Risk factors for opioid-induced respiratory depression in surgical patients: A systematic review and meta-analyses. BMJ Open. 2018; 8: e024086.

Jarzyna D, Junqquist CR, Pasero C, et al.: American Society for Pain Management Nursing guidelines on monitoring for opioid-induced sedation and respiratory depression. Pain Manage Nurs. 2011: 12(3); 118-145.

Ramachandran SK, Haider N, Saran KA, et al.: Life-threatening critical respiratory events: A retrospective study of postoperative patients found unresponsive during analgesic therapy. J Clin Anesth. 2011; 23: 207-213.